Voir/
Métadonnées
Afficher la notice complèteEvaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study.
Langue
EN
Article de revue
Ce document a été publié dans
Molecular Biology Reports. 2022-03-01, vol. 49, n° 3, p. 2321-2324
Résumé en anglais
Numerous studies demonstrate parallels between CVD, type 2 diabetes mellitus (T2DM) and COVID-19 pathology, which accentuate pre-existing complications in patients infected with COVID-19 and potentially exacerbate the infection ...Lire la suite >
Mots clés en anglais
Angiotensin-Converting Enzyme 2
Benzhydryl Compounds
COVID-19
Clinical Trials
Phase III as Topic
Double-Blind Method
Drug Repositioning
Glucosides
Heart Diseases
Humans
Kidney Diseases
Mitochondria
Multicenter Studies as Topic
Oxidative Stress
Randomized Controlled Trials as Topic
Receptors
Virus
Renin-Angiotensin System
Respiratory Insufficiency
SARS-CoV-2
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors